Sunesis Pharmaceuticals Announces Clinical Update on Vecabrutinib Program

NEXT STORY
Global Infection Control Market (2018 to 2027) – Increasing Use of E-Beam Sterilization Presents Opportunities
PREV STORY
FibroGen Announces First Patient Enrolled in Pamrevlumab Clinical Trial in Patients Hospitalized in U.S. with Acute COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AIT Therapeutics Announces Start of Manufacturing of Ventilator Compatible NO Generator and Delivery System

FDA 510(k) submission expected in the first quarter of calendar 2019 Sparton's Watertown facility ...

author_avatar
NASDAQ Market News

Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy

author_avatar
NASDAQ Market News

Madrigal Pharmaceuticals Promotes Rebecca Taub, M.D., Chief Medical Officer and Executive Vice President of Research & Development, to Newly Created Position of President of Research & Development

author_avatar
NASDAQ Market News